N-Boc-4-(2-溴乙基)哌啶结构式
|
常用名 | N-Boc-4-(2-溴乙基)哌啶 | 英文名 | tert-butyl 4-(2-bromoethyl)piperidine-1-carboxylate |
|---|---|---|---|---|
| CAS号 | 169457-73-2 | 分子量 | 292.21300 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C12H22BrNO2 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
| 中文名 | 4-(2-溴乙基)哌啶-1-羧酸叔丁酯 |
|---|---|
| 英文名 | tert-butyl 4-(2-bromoethyl)piperidine-1-carboxylate |
| 英文别名 | 更多 |
| 分子式 | C12H22BrNO2 |
|---|---|
| 分子量 | 292.21300 |
| 精确质量 | 291.08300 |
| PSA | 29.54000 |
| LogP | 3.35640 |
| InChIKey | CLBWAEYOPRGKBT-UHFFFAOYSA-N |
| SMILES | CC(C)(C)OC(=O)N1CCC(CCBr)CC1 |
| 储存条件 | 2-8°C,干燥密封 |
| 海关编码 | 2933399090 |
|---|
|
~88%
N-Boc-4-(2-溴乙基)哌啶 169457-73-2 |
| 文献:AstraZeneca AB; NPS PHARMACEUTICALS Patent: US2007/32469 A1, 2007 ; Location in patent: Page/Page column 46 ; US 20070032469 A1 |
|
~%
N-Boc-4-(2-溴乙基)哌啶 169457-73-2 |
| 文献:Glaxo Group Limited Patent: US5861414 A1, 1999 ; |
|
~%
N-Boc-4-(2-溴乙基)哌啶 169457-73-2 |
| 文献:ZIV, Ilan; Grimberg, Hagit Patent: US2011/294754 A1, 2011 ; |
|
~%
N-Boc-4-(2-溴乙基)哌啶 169457-73-2 |
| 文献:ZIV, Ilan; Grimberg, Hagit Patent: US2011/294754 A1, 2011 ; |
| N-Boc-4-(2-溴乙基)哌啶上游产品 4 | |
|---|---|
| N-Boc-4-(2-溴乙基)哌啶下游产品 2 | |
| 海关编码 | 2933399090 |
|---|---|
| 中文概述 | 2933399090. 其他结构含非稠合吡啶环的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
| 申报要素 | 品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期 |
| Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
| N-Boc-4-(2-bromoethyl)piperidine |
| 4-(2-bromo-ethyl)-piperine-1-carboxylic acid tert-butyl ester |
| 1BOC-4-BROMOETHYLPIPERIDINE |
| 1-Bromo-2-(1-t-butoxycarbonyl-4-piperidyl)ethane |
| 4-(2-bromo-ethyl)-piperidine-1-carboxylic acid tert-butyl ester |